bioRxiv · 10.1101/193797
Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae
Abstract
Antimicrobial resistant infections are a serious public health threat worldwide. Whole genome sequencing approaches to apidly identify pathogens and predict antibiotic resistance phenotypes are becoming more feasible and may offer a way to reduce clinical test turnaround times compared to conventional culture-based methods, and in turn, improve patient outcomes. In this study, we use whole genome sequence data from 1668 clinical isolates of Klebsiella pneumoniae to develop a XGBoost-based machine learning model that accurately predicts minimum inhibitory concentrations (MICs) for 20 antibiotics. The overall accuracy of the model, within {+/-}1 two-fold dilution factor, is 92%. Individual accuracies are[≥]90% for 15/20 antibiotics. We show that the MICs predicted by the model correlate with known antimicrobial resistance genes. Importantly, the genome-wide approach described in this study offers a way to predict MICs for isolates without knowledge of the underlying gene content. This study shows that machine learning can be used to build a complete in silico MIC prediction panel for K. pneumoniae and provides a framework for building MIC prediction models for other pathogenic bacteria.
Source connections
Explore related subjects
Keep this discovery
Nguyen, M., Brettin, T., Long, S. W., Olsen, R. J., Musser, J. M., Olson, R., Shukla, M., Stevens, R. L., Xia, F., Yoo, H., Davis, J.. 2017-09-25. Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae. https://doi.org/10.1101/193797
Cite the original work for its findings. Save a collection to share your selection of sources.